Clinical Trials Directory

Trials / Completed

CompletedNCT02818803

Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic

Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic in Elderly People

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of propolis on the treatment of oral candidiasis, more specifically denture stomatitis. Half of participants will receive a standardized-propolis (EPP-AF®) gel formulation while the other half will receive miconazole gel, both for oral use.

Conditions

Interventions

TypeNameDescription
OTHERPropolis
DRUGMiconazole

Timeline

Start date
2016-01-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2016-06-30
Last updated
2016-06-30

Locations

2 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02818803. Inclusion in this directory is not an endorsement.

Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic (NCT02818803) · Clinical Trials Directory